2633 — Jacobson Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Jacobson Pharma, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	221	231	340	255	374
Depreciation
Non-Cash Items	24.6	17.3	66.6	144	74.7
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-27.6	-34.4	39.2	-70.7	-65.4
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	409	407	630	484	527
Capital Expenditures	-63.4	-63.9	-63	-130	-248
Purchase of Fixed Assets
Other Investing Cash Flow Items	-310	13.9	-72	173	-49.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-373	-49.9	-135	43.3	-298
Financing Cash Flow Items	14.3	-26.6	-72.4	-81.2	-41.4
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	21.4	-358	-36.6	-1,053	-131
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	58.9	-1.7	458	-524	97.1